Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Pineda

Showing results (21-30 of 150) with videos related to

Pageof 15
Sort By:
Physiology (Bethesda, Md.)|March 18, 2005
The genetics of heteromeric amino acid transportersManuel Palacín, Virginia Nunes, Mariona Font-Llitjós, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
Constitutional MLH1 Methylation Is a Major Contributor to Mismatch Repair-Deficient, MLH1-Methylated Colorectal Cancer in Patients Aged 55 Years and YoungerMegan P Hitchins, Estela Dámaso, Rocio Alvarez, et al.
Human Mutation|October 12, 2013
GALNT12 is not a major contributor of familial colorectal cancer type XNuria Seguí, Marta Pineda, Matilde Navarro, et al.
European Journal of Human Genetics : EJHG|June 21, 2020
Evaluation of CNV detection tools for NGS panel data in genetic diagnosticsJosé Marcos Moreno-Cabrera, Jesús Del Valle, Elisabeth Castellanos, et al.
Genome Medicine|October 17, 2023
Recommendations for the classification of germline variants in the exonuclease domain of POLE and POLD1Pilar Mur, Julen Viana-Errasti, Sandra García-Mulero, et al.
Molecular Aspects of Medicine|April 3, 2019
Approaches to functionally validate candidate genetic variants involved in colorectal cancer predispositionLaia Bonjoch, Pilar Mur, Coral Arnau-Collell, et al.
Scientific Reports|November 26, 2021
RNA assay identifies a previous misclassification of BARD1 c.1977A>G variantPaula Rofes, Marta Pineda, Lídia Feliubadaló, et al.
Therapeutic Advances in Medical Oncology|June 4, 2024
Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort studyNicola L Barclay, Marti Català, Annika M Jödicke, et al.
Frontiers in Oncology|April 11, 2024
The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort studyNicola L Barclay, Marta Pineda Moncusí, Annika M Jödicke, et al.
Breast Cancer Research and Treatment|May 26, 2019
Assessment of early therapy discontinuation and health-related quality of life in breast cancer patients treated with aromatase inhibitors: B-ABLE cohort studyMarta Pineda-Moncusí, Sonia Servitja, Ignasi Tusquets, et al.
Pageof 15

Showing results (21-30 of 150) with videos related to

Sort By:
Pageof 15
Physiology (Bethesda, Md.)|March 18, 2005
The genetics of heteromeric amino acid transportersManuel Palacín, Virginia Nunes, Mariona Font-Llitjós, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
Constitutional MLH1 Methylation Is a Major Contributor to Mismatch Repair-Deficient, MLH1-Methylated Colorectal Cancer in Patients Aged 55 Years and YoungerMegan P Hitchins, Estela Dámaso, Rocio Alvarez, et al.
Human Mutation|October 12, 2013
GALNT12 is not a major contributor of familial colorectal cancer type XNuria Seguí, Marta Pineda, Matilde Navarro, et al.
European Journal of Human Genetics : EJHG|June 21, 2020
Evaluation of CNV detection tools for NGS panel data in genetic diagnosticsJosé Marcos Moreno-Cabrera, Jesús Del Valle, Elisabeth Castellanos, et al.
Genome Medicine|October 17, 2023
Recommendations for the classification of germline variants in the exonuclease domain of POLE and POLD1Pilar Mur, Julen Viana-Errasti, Sandra García-Mulero, et al.
Molecular Aspects of Medicine|April 3, 2019
Approaches to functionally validate candidate genetic variants involved in colorectal cancer predispositionLaia Bonjoch, Pilar Mur, Coral Arnau-Collell, et al.
Scientific Reports|November 26, 2021
RNA assay identifies a previous misclassification of BARD1 c.1977A>G variantPaula Rofes, Marta Pineda, Lídia Feliubadaló, et al.
Therapeutic Advances in Medical Oncology|June 4, 2024
Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort studyNicola L Barclay, Marti Català, Annika M Jödicke, et al.
Frontiers in Oncology|April 11, 2024
The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort studyNicola L Barclay, Marta Pineda Moncusí, Annika M Jödicke, et al.
Breast Cancer Research and Treatment|May 26, 2019
Assessment of early therapy discontinuation and health-related quality of life in breast cancer patients treated with aromatase inhibitors: B-ABLE cohort studyMarta Pineda-Moncusí, Sonia Servitja, Ignasi Tusquets, et al.
Pageof 15